Loading…
Clinicopathologic and prognostic significance of matrix metalloproteinases in rectal cancer
The aim of this study was to determine the prognostic role of matrix metalloproteinases in rectal cancer. Formalin-fixed and paraffin-embedded tissue sections of 94 rectal carcinomas were used for the immunohistochemical analysis of matrix metalloproteinases (MMP)-2, MMP-7, MT1-MMP, and tissue inhib...
Saved in:
| Published in: | International journal of colorectal disease 2007-02, Vol.22 (2), p.127-136 |
|---|---|
| Main Authors: | , , , |
| Format: | Article |
| Language: | English |
| Subjects: | |
| Citations: | Items that this one cites Items that cite this one |
| Online Access: | Get full text |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| cited_by | cdi_FETCH-LOGICAL-c356t-e92f8ae4eb599e6ffba727c4c7cec57e95ef922cd56145305a40a2ffb9b0d0403 |
|---|---|
| cites | cdi_FETCH-LOGICAL-c356t-e92f8ae4eb599e6ffba727c4c7cec57e95ef922cd56145305a40a2ffb9b0d0403 |
| container_end_page | 136 |
| container_issue | 2 |
| container_start_page | 127 |
| container_title | International journal of colorectal disease |
| container_volume | 22 |
| creator | SCHWANDNER, O SCHLAMP, A BROIL, R BRUCH, H. P |
| description | The aim of this study was to determine the prognostic role of matrix metalloproteinases in rectal cancer.
Formalin-fixed and paraffin-embedded tissue sections of 94 rectal carcinomas were used for the immunohistochemical analysis of matrix metalloproteinases (MMP)-2, MMP-7, MT1-MMP, and tissue inhibitor of metalloproteinases (TIMP)-2. Inclusion criteria were sporadic rectal adenocarcinoma resected curatively (including total mesorectal excision), adjuvant radiochemotherapy in UICC stages II and III, and complete intra-institutional follow-up. Results of immunohistochemistry were correlated with clinical and histopathologic data from the prospective rectal cancer registry and prognosis. End points of the prognostic analysis were tumor progression caused by local and/or distant recurrence and 5-year survival (disease-free and overall). To assess prognostic significance, statistics included univariate and multivariate analysis (p |
| doi_str_mv | 10.1007/s00384-006-0173-y |
| format | article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_68377370</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1192545941</sourcerecordid><originalsourceid>FETCH-LOGICAL-c356t-e92f8ae4eb599e6ffba727c4c7cec57e95ef922cd56145305a40a2ffb9b0d0403</originalsourceid><addsrcrecordid>eNpdkE1rGzEQhkVJaBy3P6CXsBSS26YjaSWtjsXko2DopT31IGR55MrsSo60hvjfV64NgZyGGZ6ZeXkI-ULhngKobwWA910LIFugireHD2RGO85ayiS7ILM61C3Vor8i16VsofZSdR_JFZW9llqzGfmzGEIMLu3s9DcNaRNcY-O62eW0ialMtS1hE4MPzkaHTfLNaKccXpsRJzsMqYIThmgLlibEJqOr4-Y_nD-RS2-Hgp_PdU5-Pz78Wjy3y59PPxbfl63jQk4tauZ7ix2uhNYovV9ZxZTrnHLohEIt0GvG3FpI2gkOwnZgWcX0CtbQAZ-Tu9PdGuZlj2UyYygOh8FGTPtiZM-V4uoIfn0HbtM-x5rNMCoFKC1EhegJcjmVktGbXQ6jzQdDwRy1m5N2U7Wbo3ZzqDs358P71Yjrt42z5wrcngFbnB18roJCeeP6-hwo4_8AOjeMow</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>216507955</pqid></control><display><type>article</type><title>Clinicopathologic and prognostic significance of matrix metalloproteinases in rectal cancer</title><source>Springer Nature</source><creator>SCHWANDNER, O ; SCHLAMP, A ; BROIL, R ; BRUCH, H. P</creator><creatorcontrib>SCHWANDNER, O ; SCHLAMP, A ; BROIL, R ; BRUCH, H. P</creatorcontrib><description><![CDATA[The aim of this study was to determine the prognostic role of matrix metalloproteinases in rectal cancer.
Formalin-fixed and paraffin-embedded tissue sections of 94 rectal carcinomas were used for the immunohistochemical analysis of matrix metalloproteinases (MMP)-2, MMP-7, MT1-MMP, and tissue inhibitor of metalloproteinases (TIMP)-2. Inclusion criteria were sporadic rectal adenocarcinoma resected curatively (including total mesorectal excision), adjuvant radiochemotherapy in UICC stages II and III, and complete intra-institutional follow-up. Results of immunohistochemistry were correlated with clinical and histopathologic data from the prospective rectal cancer registry and prognosis. End points of the prognostic analysis were tumor progression caused by local and/or distant recurrence and 5-year survival (disease-free and overall). To assess prognostic significance, statistics included univariate and multivariate analysis (p<0.05 statistically significant).
Of the 94 rectal carcinomas, 35% (33/94) showed an epithelial MMP-2 expression, 77% (72/94) were MMP-2 positive in the stroma. Fifty-four percent (51/94) were MMP-7 positive, and 47% (46/94) were positive for both MT1-MMP and TIMP-2. The stromal MMP-2 staining pattern was correlated with the depth of invasion (pT status, p=0.006) with MMP-7 (p=0.016) and TIMP-2 expression (p=0.036). Positive expression of MMP-2 in tumor epithelium was correlated with MMP-7 (p=0.027), MT1-MMP (p=0.036), and TIMP-2 expression (p<0.0001). A positive staining pattern of MMP-7 was significantly correlated with depth of invasion and TIMP-2 (p<0.01). The positive staining pattern of MT1-MMP was correlated with epithelial MMP-2 (p=0.036), MMP-7 (p=0.004), and TIMP-2 expression (p=0.002). TIMP-2 immunoreactivity correlated with depth of invasion (p=0.013), epithelial MMP-2 (p<0.001), stromal MMP-2 (p=0.036), MMP-7 (p<0.001), and MT1-MMP (p=0.002). Neither pattern correlated with age, gender, tumor stage (UICC), grading, preoperative serum carcinoembryonic antigen (CEA) level, or nodal status (p>0.05). Within a mean follow-up of 46 months, tumor progression, caused by either local recurrence or distant metastasis, occurred in 14 patients (15.4%). There was no significant association between the MMP expression and the incidence of local and/or distant recurrence. In terms of survival, preoperative CEA level (disease-free 5-year survival 46% with increased CEA vs 70% with normal CEA, p=0.01; overall 5-year survival 43 vs 74%, p<0.01) and UICC stage were the only factors to be significantly related to 5-year survival by univariate analysis, whereas the metalloproteinases failed to show a significant association. In multivariate analysis, CEA and UICC stage were not identified as independent factors predictive of survival.
MMP-2, MMP-7, MT1-MMP, and TIMP-2 do not appear to be significant predictors of prognosis in a homogenous collective of curatively resected rectal adenocarcinomas.]]></description><identifier>ISSN: 0179-1958</identifier><identifier>EISSN: 1432-1262</identifier><identifier>DOI: 10.1007/s00384-006-0173-y</identifier><identifier>PMID: 16896992</identifier><identifier>CODEN: IJCDE6</identifier><language>eng</language><publisher>Heidelberg: Springer</publisher><subject>Adenocarcinoma - chemistry ; Adenocarcinoma - metabolism ; Adenocarcinoma - pathology ; Adult ; Aged ; Aged, 80 and over ; Biological and medical sciences ; Female ; Gastroenterology. Liver. Pancreas. Abdomen ; Humans ; Immunohistochemistry ; Male ; Matrix Metalloproteinase 14 - analysis ; Matrix Metalloproteinase 14 - biosynthesis ; Matrix Metalloproteinase 2 - analysis ; Matrix Metalloproteinase 2 - biosynthesis ; Matrix Metalloproteinase 7 - analysis ; Matrix Metalloproteinase 7 - biosynthesis ; Medical sciences ; Middle Aged ; Predictive Value of Tests ; Rectal Neoplasms - chemistry ; Rectal Neoplasms - metabolism ; Rectal Neoplasms - pathology ; Stomach. Duodenum. Small intestine. Colon. Rectum. Anus ; Survival Analysis ; Tissue Inhibitor of Metalloproteinase-2 - analysis ; Tissue Inhibitor of Metalloproteinase-2 - biosynthesis ; Tumors</subject><ispartof>International journal of colorectal disease, 2007-02, Vol.22 (2), p.127-136</ispartof><rights>2007 INIST-CNRS</rights><rights>Springer-Verlag 2007</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c356t-e92f8ae4eb599e6ffba727c4c7cec57e95ef922cd56145305a40a2ffb9b0d0403</citedby><cites>FETCH-LOGICAL-c356t-e92f8ae4eb599e6ffba727c4c7cec57e95ef922cd56145305a40a2ffb9b0d0403</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=18507012$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/16896992$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>SCHWANDNER, O</creatorcontrib><creatorcontrib>SCHLAMP, A</creatorcontrib><creatorcontrib>BROIL, R</creatorcontrib><creatorcontrib>BRUCH, H. P</creatorcontrib><title>Clinicopathologic and prognostic significance of matrix metalloproteinases in rectal cancer</title><title>International journal of colorectal disease</title><addtitle>Int J Colorectal Dis</addtitle><description><![CDATA[The aim of this study was to determine the prognostic role of matrix metalloproteinases in rectal cancer.
Formalin-fixed and paraffin-embedded tissue sections of 94 rectal carcinomas were used for the immunohistochemical analysis of matrix metalloproteinases (MMP)-2, MMP-7, MT1-MMP, and tissue inhibitor of metalloproteinases (TIMP)-2. Inclusion criteria were sporadic rectal adenocarcinoma resected curatively (including total mesorectal excision), adjuvant radiochemotherapy in UICC stages II and III, and complete intra-institutional follow-up. Results of immunohistochemistry were correlated with clinical and histopathologic data from the prospective rectal cancer registry and prognosis. End points of the prognostic analysis were tumor progression caused by local and/or distant recurrence and 5-year survival (disease-free and overall). To assess prognostic significance, statistics included univariate and multivariate analysis (p<0.05 statistically significant).
Of the 94 rectal carcinomas, 35% (33/94) showed an epithelial MMP-2 expression, 77% (72/94) were MMP-2 positive in the stroma. Fifty-four percent (51/94) were MMP-7 positive, and 47% (46/94) were positive for both MT1-MMP and TIMP-2. The stromal MMP-2 staining pattern was correlated with the depth of invasion (pT status, p=0.006) with MMP-7 (p=0.016) and TIMP-2 expression (p=0.036). Positive expression of MMP-2 in tumor epithelium was correlated with MMP-7 (p=0.027), MT1-MMP (p=0.036), and TIMP-2 expression (p<0.0001). A positive staining pattern of MMP-7 was significantly correlated with depth of invasion and TIMP-2 (p<0.01). The positive staining pattern of MT1-MMP was correlated with epithelial MMP-2 (p=0.036), MMP-7 (p=0.004), and TIMP-2 expression (p=0.002). TIMP-2 immunoreactivity correlated with depth of invasion (p=0.013), epithelial MMP-2 (p<0.001), stromal MMP-2 (p=0.036), MMP-7 (p<0.001), and MT1-MMP (p=0.002). Neither pattern correlated with age, gender, tumor stage (UICC), grading, preoperative serum carcinoembryonic antigen (CEA) level, or nodal status (p>0.05). Within a mean follow-up of 46 months, tumor progression, caused by either local recurrence or distant metastasis, occurred in 14 patients (15.4%). There was no significant association between the MMP expression and the incidence of local and/or distant recurrence. In terms of survival, preoperative CEA level (disease-free 5-year survival 46% with increased CEA vs 70% with normal CEA, p=0.01; overall 5-year survival 43 vs 74%, p<0.01) and UICC stage were the only factors to be significantly related to 5-year survival by univariate analysis, whereas the metalloproteinases failed to show a significant association. In multivariate analysis, CEA and UICC stage were not identified as independent factors predictive of survival.
MMP-2, MMP-7, MT1-MMP, and TIMP-2 do not appear to be significant predictors of prognosis in a homogenous collective of curatively resected rectal adenocarcinomas.]]></description><subject>Adenocarcinoma - chemistry</subject><subject>Adenocarcinoma - metabolism</subject><subject>Adenocarcinoma - pathology</subject><subject>Adult</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Biological and medical sciences</subject><subject>Female</subject><subject>Gastroenterology. Liver. Pancreas. Abdomen</subject><subject>Humans</subject><subject>Immunohistochemistry</subject><subject>Male</subject><subject>Matrix Metalloproteinase 14 - analysis</subject><subject>Matrix Metalloproteinase 14 - biosynthesis</subject><subject>Matrix Metalloproteinase 2 - analysis</subject><subject>Matrix Metalloproteinase 2 - biosynthesis</subject><subject>Matrix Metalloproteinase 7 - analysis</subject><subject>Matrix Metalloproteinase 7 - biosynthesis</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Predictive Value of Tests</subject><subject>Rectal Neoplasms - chemistry</subject><subject>Rectal Neoplasms - metabolism</subject><subject>Rectal Neoplasms - pathology</subject><subject>Stomach. Duodenum. Small intestine. Colon. Rectum. Anus</subject><subject>Survival Analysis</subject><subject>Tissue Inhibitor of Metalloproteinase-2 - analysis</subject><subject>Tissue Inhibitor of Metalloproteinase-2 - biosynthesis</subject><subject>Tumors</subject><issn>0179-1958</issn><issn>1432-1262</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2007</creationdate><recordtype>article</recordtype><recordid>eNpdkE1rGzEQhkVJaBy3P6CXsBSS26YjaSWtjsXko2DopT31IGR55MrsSo60hvjfV64NgZyGGZ6ZeXkI-ULhngKobwWA910LIFugireHD2RGO85ayiS7ILM61C3Vor8i16VsofZSdR_JFZW9llqzGfmzGEIMLu3s9DcNaRNcY-O62eW0ialMtS1hE4MPzkaHTfLNaKccXpsRJzsMqYIThmgLlibEJqOr4-Y_nD-RS2-Hgp_PdU5-Pz78Wjy3y59PPxbfl63jQk4tauZ7ix2uhNYovV9ZxZTrnHLohEIt0GvG3FpI2gkOwnZgWcX0CtbQAZ-Tu9PdGuZlj2UyYygOh8FGTPtiZM-V4uoIfn0HbtM-x5rNMCoFKC1EhegJcjmVktGbXQ6jzQdDwRy1m5N2U7Wbo3ZzqDs358P71Yjrt42z5wrcngFbnB18roJCeeP6-hwo4_8AOjeMow</recordid><startdate>20070201</startdate><enddate>20070201</enddate><creator>SCHWANDNER, O</creator><creator>SCHLAMP, A</creator><creator>BROIL, R</creator><creator>BRUCH, H. P</creator><general>Springer</general><general>Springer Nature B.V</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7T5</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>H94</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>7X8</scope></search><sort><creationdate>20070201</creationdate><title>Clinicopathologic and prognostic significance of matrix metalloproteinases in rectal cancer</title><author>SCHWANDNER, O ; SCHLAMP, A ; BROIL, R ; BRUCH, H. P</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c356t-e92f8ae4eb599e6ffba727c4c7cec57e95ef922cd56145305a40a2ffb9b0d0403</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2007</creationdate><topic>Adenocarcinoma - chemistry</topic><topic>Adenocarcinoma - metabolism</topic><topic>Adenocarcinoma - pathology</topic><topic>Adult</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Biological and medical sciences</topic><topic>Female</topic><topic>Gastroenterology. Liver. Pancreas. Abdomen</topic><topic>Humans</topic><topic>Immunohistochemistry</topic><topic>Male</topic><topic>Matrix Metalloproteinase 14 - analysis</topic><topic>Matrix Metalloproteinase 14 - biosynthesis</topic><topic>Matrix Metalloproteinase 2 - analysis</topic><topic>Matrix Metalloproteinase 2 - biosynthesis</topic><topic>Matrix Metalloproteinase 7 - analysis</topic><topic>Matrix Metalloproteinase 7 - biosynthesis</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Predictive Value of Tests</topic><topic>Rectal Neoplasms - chemistry</topic><topic>Rectal Neoplasms - metabolism</topic><topic>Rectal Neoplasms - pathology</topic><topic>Stomach. Duodenum. Small intestine. Colon. Rectum. Anus</topic><topic>Survival Analysis</topic><topic>Tissue Inhibitor of Metalloproteinase-2 - analysis</topic><topic>Tissue Inhibitor of Metalloproteinase-2 - biosynthesis</topic><topic>Tumors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>SCHWANDNER, O</creatorcontrib><creatorcontrib>SCHLAMP, A</creatorcontrib><creatorcontrib>BROIL, R</creatorcontrib><creatorcontrib>BRUCH, H. P</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Immunology Abstracts</collection><collection>ProQuest Health and Medical</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>MEDLINE - Academic</collection><jtitle>International journal of colorectal disease</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>SCHWANDNER, O</au><au>SCHLAMP, A</au><au>BROIL, R</au><au>BRUCH, H. P</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Clinicopathologic and prognostic significance of matrix metalloproteinases in rectal cancer</atitle><jtitle>International journal of colorectal disease</jtitle><addtitle>Int J Colorectal Dis</addtitle><date>2007-02-01</date><risdate>2007</risdate><volume>22</volume><issue>2</issue><spage>127</spage><epage>136</epage><pages>127-136</pages><issn>0179-1958</issn><eissn>1432-1262</eissn><coden>IJCDE6</coden><abstract><![CDATA[The aim of this study was to determine the prognostic role of matrix metalloproteinases in rectal cancer.
Formalin-fixed and paraffin-embedded tissue sections of 94 rectal carcinomas were used for the immunohistochemical analysis of matrix metalloproteinases (MMP)-2, MMP-7, MT1-MMP, and tissue inhibitor of metalloproteinases (TIMP)-2. Inclusion criteria were sporadic rectal adenocarcinoma resected curatively (including total mesorectal excision), adjuvant radiochemotherapy in UICC stages II and III, and complete intra-institutional follow-up. Results of immunohistochemistry were correlated with clinical and histopathologic data from the prospective rectal cancer registry and prognosis. End points of the prognostic analysis were tumor progression caused by local and/or distant recurrence and 5-year survival (disease-free and overall). To assess prognostic significance, statistics included univariate and multivariate analysis (p<0.05 statistically significant).
Of the 94 rectal carcinomas, 35% (33/94) showed an epithelial MMP-2 expression, 77% (72/94) were MMP-2 positive in the stroma. Fifty-four percent (51/94) were MMP-7 positive, and 47% (46/94) were positive for both MT1-MMP and TIMP-2. The stromal MMP-2 staining pattern was correlated with the depth of invasion (pT status, p=0.006) with MMP-7 (p=0.016) and TIMP-2 expression (p=0.036). Positive expression of MMP-2 in tumor epithelium was correlated with MMP-7 (p=0.027), MT1-MMP (p=0.036), and TIMP-2 expression (p<0.0001). A positive staining pattern of MMP-7 was significantly correlated with depth of invasion and TIMP-2 (p<0.01). The positive staining pattern of MT1-MMP was correlated with epithelial MMP-2 (p=0.036), MMP-7 (p=0.004), and TIMP-2 expression (p=0.002). TIMP-2 immunoreactivity correlated with depth of invasion (p=0.013), epithelial MMP-2 (p<0.001), stromal MMP-2 (p=0.036), MMP-7 (p<0.001), and MT1-MMP (p=0.002). Neither pattern correlated with age, gender, tumor stage (UICC), grading, preoperative serum carcinoembryonic antigen (CEA) level, or nodal status (p>0.05). Within a mean follow-up of 46 months, tumor progression, caused by either local recurrence or distant metastasis, occurred in 14 patients (15.4%). There was no significant association between the MMP expression and the incidence of local and/or distant recurrence. In terms of survival, preoperative CEA level (disease-free 5-year survival 46% with increased CEA vs 70% with normal CEA, p=0.01; overall 5-year survival 43 vs 74%, p<0.01) and UICC stage were the only factors to be significantly related to 5-year survival by univariate analysis, whereas the metalloproteinases failed to show a significant association. In multivariate analysis, CEA and UICC stage were not identified as independent factors predictive of survival.
MMP-2, MMP-7, MT1-MMP, and TIMP-2 do not appear to be significant predictors of prognosis in a homogenous collective of curatively resected rectal adenocarcinomas.]]></abstract><cop>Heidelberg</cop><cop>Berlin</cop><pub>Springer</pub><pmid>16896992</pmid><doi>10.1007/s00384-006-0173-y</doi><tpages>10</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0179-1958 |
| ispartof | International journal of colorectal disease, 2007-02, Vol.22 (2), p.127-136 |
| issn | 0179-1958 1432-1262 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_68377370 |
| source | Springer Nature |
| subjects | Adenocarcinoma - chemistry Adenocarcinoma - metabolism Adenocarcinoma - pathology Adult Aged Aged, 80 and over Biological and medical sciences Female Gastroenterology. Liver. Pancreas. Abdomen Humans Immunohistochemistry Male Matrix Metalloproteinase 14 - analysis Matrix Metalloproteinase 14 - biosynthesis Matrix Metalloproteinase 2 - analysis Matrix Metalloproteinase 2 - biosynthesis Matrix Metalloproteinase 7 - analysis Matrix Metalloproteinase 7 - biosynthesis Medical sciences Middle Aged Predictive Value of Tests Rectal Neoplasms - chemistry Rectal Neoplasms - metabolism Rectal Neoplasms - pathology Stomach. Duodenum. Small intestine. Colon. Rectum. Anus Survival Analysis Tissue Inhibitor of Metalloproteinase-2 - analysis Tissue Inhibitor of Metalloproteinase-2 - biosynthesis Tumors |
| title | Clinicopathologic and prognostic significance of matrix metalloproteinases in rectal cancer |
| url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-27T16%3A05%3A17IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Clinicopathologic%20and%20prognostic%20significance%20of%20matrix%20metalloproteinases%20in%20rectal%20cancer&rft.jtitle=International%20journal%20of%20colorectal%20disease&rft.au=SCHWANDNER,%20O&rft.date=2007-02-01&rft.volume=22&rft.issue=2&rft.spage=127&rft.epage=136&rft.pages=127-136&rft.issn=0179-1958&rft.eissn=1432-1262&rft.coden=IJCDE6&rft_id=info:doi/10.1007/s00384-006-0173-y&rft_dat=%3Cproquest_cross%3E1192545941%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c356t-e92f8ae4eb599e6ffba727c4c7cec57e95ef922cd56145305a40a2ffb9b0d0403%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=216507955&rft_id=info:pmid/16896992&rfr_iscdi=true |